- Home
- FCFS vs ELAN Comparison
FCFS vs ELAN Comparison
Compare FCFS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCFS
- ELAN
- Stock Information
- Founded
- FCFS 1988
- ELAN 1954
- Country
- FCFS United States
- ELAN United States
- Employees
- FCFS N/A
- ELAN N/A
- Industry
- FCFS Other Specialty Stores
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- FCFS Consumer Discretionary
- ELAN Health Care
- Exchange
- FCFS Nasdaq
- ELAN Nasdaq
- Market Cap
- FCFS 5.9B
- ELAN 6.6B
- IPO Year
- FCFS 1991
- ELAN 2018
- Fundamental
- Price
- FCFS $136.77
- ELAN $14.64
- Analyst Decision
- FCFS Strong Buy
- ELAN Buy
- Analyst Count
- FCFS 2
- ELAN 7
- Target Price
- FCFS $133.50
- ELAN $15.33
- AVG Volume (30 Days)
- FCFS 300.8K
- ELAN 5.3M
- Earning Date
- FCFS 07-24-2025
- ELAN 08-07-2025
- Dividend Yield
- FCFS 1.11%
- ELAN N/A
- EPS Growth
- FCFS 21.73
- ELAN N/A
- EPS
- FCFS 6.25
- ELAN 0.75
- Revenue
- FCFS $3,388,567,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- FCFS $3.70
- ELAN $4.28
- Revenue Next Year
- FCFS $6.60
- ELAN $4.67
- P/E Ratio
- FCFS $21.89
- ELAN $19.53
- Revenue Growth
- FCFS 5.06
- ELAN 1.42
- 52 Week Low
- FCFS $100.24
- ELAN $8.02
- 52 Week High
- FCFS $138.42
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- FCFS 65.10
- ELAN 69.06
- Support Level
- FCFS $129.72
- ELAN $14.01
- Resistance Level
- FCFS $138.42
- ELAN $14.15
- Average True Range (ATR)
- FCFS 2.69
- ELAN 0.40
- MACD
- FCFS 0.58
- ELAN 0.01
- Stochastic Oscillator
- FCFS 84.06
- ELAN 89.70
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.